Taking the opportunity to leverage its commercial expertise with the product TOBI, Chiron Corp. acquired exclusive worldwide development and commercial rights to a product being developed by Novartis AG. (BioWorld Today)
As a small privately held company with 22 employees, GeneSoft Pharmaceuticals Inc. appears to be on a roll, finding its niche in three different areas of drug development. (BioWorld Today)
As a small privately held company with 22 employees, GeneSoft Pharmaceuticals Inc. appears to be on a roll, finding its niche in three different areas of drug development. (BioWorld Today)
